A novel biomarker Ins60/ApoA for predicting diabetic kidney disease in newly diagnosed type 2 diabetes: a pilot study
The ratio of Ins60/ApoA could be used as an alternative biomarker for predicting DKD in newly diagnosed T2DM patients.
Authors
- Wanwan Zhang (ORCID: https://orcid.org/0000-0001-7058-9664)
- Hao Hu (ORCID: https://orcid.org/0000-0002-3567-609X)
- Binbin Pan (ORCID: https://orcid.org/0000-0001-6440-4758)
- Xia Wan (ORCID: https://orcid.org/0000-0002-0738-5631)
- Hao Zhang (ORCID: https://orcid.org/0000-0002-9938-8433)
- Sun Jin (ORCID: https://orcid.org/0009-0007-7437-0417)
- Yuanyuan Liu (ORCID: https://orcid.org/0009-0004-8170-5308)
- Mengqing Ma (ORCID: https://orcid.org/0000-0003-4402-7988)
Institutions
- Xuzhou Medical College (CN)
- Xuzhou No.1 People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-09
- DOI
- https://doi.org/10.3389/fmed.2025.1569730
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00